Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases

被引:0
|
作者
Kihara, Sayaka [1 ,2 ]
Ohira, Shingo [1 ,3 ]
Kanayama, Naoyuki [1 ]
Ikawa, Toshiki [1 ]
Inui, Shoki [1 ]
Isono, Masaru [1 ]
Nitta, Yuya [1 ]
Ueda, Yoshihiro [1 ]
Nishio, Teiji [2 ]
Konishi, Koji [1 ]
机构
[1] Osaka Int Canc Inst, Dept Radiat Oncol, 3-1-69 Otemae,Chuo Ku, Osaka 5418567, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Med Phys Lab, Osaka, Japan
[3] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan
来源
IN VIVO | 2025年 / 39卷 / 01期
关键词
Stereotactic radiosurgery; brain metastases; HyperArc; volumetric modulated arc therapy; linear accelerator; RADIOSURGERY;
D O I
10.21873/invivo.13819
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: HyperArc (HA) is an automated planning technique enabling single-isocenter brain stereotactic radiotherapy (SRT); however, dosimetric outcomes may be influenced by the planner's expertise. This study aimed to assess the impact of institutional experience on the plan quality of HA-SRT for both single and multiple brain metastases. Materials and Methods: Twenty patients who underwent HASRT for single metastasis between 2020 and 2021 comprised the earlier group, while those treated between 2022 and 2024 constituted the later group. For multiple metastases, 40 patients who received HA-SRT from 2020 2024 were divided into earlier and later treatment groups. Dosimetric parameters including gross tumor volume (GTV) doses (D98% and Dmean), volumes of the normal brain (Brain-GTV V25Gy and V30Gy), homogeneity index (HI), gradient index (GI), and total monitor unit (MU) were compared. A linear regression model was used to evaluate the effects of planning target volume (PTV) on volumes of normal brain via interaction between PTV volume and treatment era group (earlier vs. later). Results: The later group exhibited significantly higher D98% and Dmean values for both single and multiple metastases, while V25Gy and V30Gy and GI mean values were comparable. Consequently, mean HI and total MU values increased significantly. Both single and multiple metastases showed significant interaction between PTV volume and treatment era group. Conclusion: Enhanced dosimetric outcomes in the later group suggested that accumulated experience contributed to improve GTV and brain dose in HA SRT. Institutional experience is important to improve the plan quality for SRT even with automatic planning such as HA.
引用
收藏
页码:210 / 217
页数:8
相关论文
共 50 条
  • [21] Stereotactic radiosurgery and radiotherapy for brain metastases
    Tanguy, Ronan
    Metellus, Philippe
    Mornex, Francoise
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2013, 100 (01) : 75 - 81
  • [22] Comparison between the HyperArc™ technique and the CyberKnife® technique for stereotactic treatment of brain metastases
    Guinement, L.
    Salleron, J.
    Buchheit, I.
    Gerard, K.
    Faivre, J. -C.
    Royer, P.
    Marchesi, V.
    CANCER RADIOTHERAPIE, 2023, 27 (02): : 136 - 144
  • [23] Influence of Technological Advances and Institutional Experience on Outcome of Stereotactic Body Radiotherapy for Lung Metastases
    Hoerner-Rieber, Juliane
    Abbassi-Senger, Nasrin
    Adebahr, Sonja
    Andratschke, Nicolaus
    Blanck, Oliver
    Duma, Marciana
    Eble, Michael J.
    Ernst, Iris
    Flentje, Michael
    Gerum, Sabine
    Hass, Peter
    Henkenberens, Christoph
    Hildebrandt, Guido
    Imhoff, Detlef
    Kahl, Henning
    Krempien, Robert
    Klass, Nathalie Desiree
    Lohaus, Fabian
    Lohr, Frank
    Petersen, Cordula
    Schrade, Elsge
    Streblow, Jan
    Uhlmann, Lorenz
    Wittig, Andrea
    Sterzing, Florian
    Guckenberger, Matthias
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1058 - S1059
  • [24] Stereotactic radiotherapy using linear accelerator in patients with brain metastases
    Grosu, AL
    Feldmann, HJ
    Stärk, S
    Pinsker, M
    Nieder, C
    Kneschaurek, P
    Lumenta, C
    Molls, M
    NERVENARZT, 2001, 72 (10): : 770 - 781
  • [25] Whole-brain radiotherapy with hippocampus sparing and simultaneous integrated boost to metastases: A plan quality comparison study between Ethos, HyperArc, VMAT and Tomotherapy
    Akdeniz, Yucel
    Ispir, Burcin
    MEDICAL DOSIMETRY, 2024, 49 (03) : 185 - 191
  • [26] The Treatment Plan of Brain Metastases with Stereotactic Radiosurgery
    Mucollari, Irena
    Xhumari, Artur
    Aliraj, Aurora
    Mano, Anastela
    Brace, Gramoz
    Tafaj, Rejnardo
    Cullhaj, Bledar
    Larti, Eldisa
    10TH JUBILEE CONFERENCE OF THE BALKAN PHYSICAL UNION, 2019, 2075
  • [27] Radiosurgery and stereotactic radiotherapy for brain metastases: an early single-institution experience
    Borzillo, V.
    Giugliano, F. M.
    Di Franco, R.
    Falivene, S.
    Iadanza, L.
    Mormile, M.
    Ravo, V.
    Muto, P.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S4 - S5
  • [28] Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases
    Giubilei, Cesare
    Ingrosso, Gianluca
    D'Andrea, Marco
    Benassi, Michaela
    Santoni, Riccardo
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (02) : 207 - 212
  • [29] Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases
    Cesare Giubilei
    Gianluca Ingrosso
    Marco D’Andrea
    Michaela Benassi
    Riccardo Santoni
    Journal of Neuro-Oncology, 2009, 91 : 207 - 212
  • [30] Automated Planning and Delivery of Hippocampal Avoidance Whole-Brain Radiotherapy for Brain Metastases Using HyperArc Technology
    Rusu, I.
    Conrad, B.
    Steber, J.
    Solanki, A.
    Melian, E.
    Roeske, J.
    MEDICAL PHYSICS, 2019, 46 (06) : E438 - E438